Institute

Back to overview
Name

Klinik und Poliklinik für Med. Onkologie Inselspital

Address Klinik und Poliklinik für Med. Onkologie Inselspital
Freiburgstrasse 10
3010
CH-Bern
Show all

Projects

Responsible applicant Institution of higher education Start End date Funding scheme

Application of DNA markers to the study of clonality in human solid tumors
Fey Martin F. University of Berne - BE 01.10.1990 30.09.1993 Project funding (Div. I-III)

Gene regulation in normal and leukaemic myeloid differentiation
Fey Martin F. University of Berne - BE 01.04.2006 30.04.2010 Project funding (Div. I-III)

Complex deregulation of myeloid key transcription factors by distal regulatory elements in acute myeloid leukemia (AML) patients.
Pabst Thomas University of Berne - BE 01.10.2012 30.09.2016 Project funding (Div. I-III)

The block in differentiation in CBF leukemias is caused by suppression of the myeloid key transcription factor CEBPA, mediated by activation of Calreticulin
Pabst Thomas University of Berne - BE 01.01.2006 30.04.2009 Project funding (Div. I-III)

The dual role of CD27 signaling in chronic viral infections and tumors
Ochsenbein Adrian Franz University of Berne - BE 01.01.2008 31.12.2010 Project funding (Div. I-III)

Normal and neoplastic cells of the hematopoiesis as target cells for natural killer cytotoxicity and lymphokine-activated killer cytotoxicity
von Rohr Albert University of Berne - BE 01.10.1994 30.09.1996 Project funding (Div. I-III)

TNF receptor TNIK signaling in the regulation of myelopoiesis and T cell function
Ochsenbein Adrian Franz University of Berne - BE 01.01.2014 31.12.2016 Project funding (Div. I-III)

Molecular mechanisms of the adaptive immune system involved in cancer progression
Ochsenbein Adrian Franz University of Berne - BE 01.01.2011 31.12.2013 Project funding (Div. I-III)

The block in differentiation in CBF leukemias is mediated by the transcription factor C/EBPa, a critical CBF target gene.
Pabst Thomas University of Berne - BE 01.07.2002 31.12.2005 Project funding (Div. I-III)

Functional analysis of the Death-associated protein kinase 2 (DAPK2) signalling pathway in acute myeloid leukaemias
Fey Martin F. University of Berne - BE 01.04.2010 30.09.2013 Project funding (Div. I-III)

Induction of T cell mediated tumor specific immunity in breast cancer. (S C O R E A)
Gimmi Claude University of Berne - BE 01.01.1996 31.12.2000 Ambizione

Molecular assessment of clonality and clonal heterogeneity in human neoplasia (Finanziert aus dem Erika Harre-Fonds)
Fey Martin F. University of Berne - BE 01.10.1993 30.09.1995 Project funding (Div. I-III)

Targeting TNF receptor TNIK signaling to eliminate cancer stem cells
Ochsenbein Adrian Franz University of Berne - BE 01.01.2017 30.06.2020 Project funding (Div. I-III)

Activation of the unfolded protein response in acute myeloid leukemia.
Pabst Thomas University of Berne - BE 01.10.2009 30.09.2012 Project funding (Div. I-III)

Induction of T cell mediated tumor specific immunity against breast cancer.
Gimmi Claude University of Berne - BE 01.01.1997 31.03.2000 Project funding (Div. I-III)

Dissecting the role of autophagy in normal and malignant B cells towards a rational, possibly novel therapeutic target
Novak Urban University of Berne - BE 01.01.2017 30.04.2021 Project funding (Div. I-III)

Vergleichende Untersuchung der Lebensqualität von Patienten/innenmit metastasierendem Brust- oder Darmkrebs behandelt in der An- throposophischen Medizin oder in der Schulmedizin ...
Cerny Thomas University of Berne - BE 01.05.1993 30.04.1998 NRP 34 Complementary Medicine

Immunosurveillance of tumors in mice and humans studied after adoptive transfer of specific CD4+ and CD8+ T cells
Ochsenbein Adrian Franz University of Berne - BE 01.01.2003 31.12.2007 SNSF Professorships

Detection of DNA markers for clonal cell populations (including malignant tumours) by Southern blot hybridisation
Fey Martin F. University of Berne - BE 01.10.1988 30.09.1990 Project funding (Div. I-III)
-